Scholar Rock Holding Corp (SRRK) stock
SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$48.00+2.92 (+6.48%)
Close on Nov 18, 2026Market cap $5.85BP/E –Yield –
Scholar Rock operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Scholar Rock's operating cash flow for the twelve months ending Jun 30, 2026 was -$296.83M. For fiscal 2025 it was -$300.04M. The highest annual figure on record is $24.57M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$300.04M | – |
| FY2024 | Dec 31, 2024 | -$200.95M | – |
| FY2023 | Dec 31, 2023 | -$145.23M | – |
| FY2022 | Dec 31, 2022 | -$132.69M | – |
| FY2021 | Dec 31, 2021 | -$126.79M | – |
| FY2020 | Dec 31, 2020 | -$60.27M | – |
| FY2019 | Dec 31, 2019 | -$63.12M | -356.9% |
| FY2018 | Dec 31, 2018 | $24.57M | – |
| FY2017 | Dec 31, 2017 | -$21.74M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$70.31M | – |
| Q1 FY2026 | Mar 31, 2026 | -$82.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$75.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$68.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$76.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$78.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$49.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$52.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$49.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$49.79M | – |
| Q4 FY2023 | Dec 31, 2023 | -$37.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$32.27M | – |
| Q2 FY2023 | Jun 30, 2023 | -$32.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$43.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$28.91M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$34.74M | – |
| Q1 FY2022 | Mar 31, 2022 | -$42.57M | – |
| Q4 FY2021 | Dec 31, 2021 | -$32.46M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$31.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.54M | -1107.0% |
| Q4 FY2020 | Dec 31, 2020 | -$19.69M | – |
| Q3 FY2020 | Sep 30, 2020 | -$23.40M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.83M | – |
| Q1 FY2020 | Mar 31, 2020 | $2.64M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.07M | -129.2% |
| Q3 FY2019 | Sep 30, 2019 | -$15.11M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.41M | – |
| Q1 FY2019 | Mar 31, 2019 | -$15.53M | – |
| Q4 FY2018 | Dec 31, 2018 | $55.09M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.01M | – |
| Q2 FY2018 | Jun 30, 2018 | -$11.63M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.88M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.06M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.75M | – |
See a number that looks wrong?